Medical News

RSS

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announced today that the US Food and Drug Administration has granted orphan-drug designation to the investigational drug XEN402 being developed for the treatment of pain associated with erythromelalgia.

24 Apr 2013

Data from MK-5172 Phase II study for treatment of HCV genotype 1 infection to be presented at EASL meeting

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial evaluating the safety and antiviral activity of MK-5172, for the treatment of chronic hepatitis C virus genotype 1 infection.

24 Apr 2013

Sucampo's supplemental new drug application for AMITIZA gets FDA approval

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that the United States Food and Drug Administration has approved Sucampo's supplemental new drug application for AMITIZA (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.

24 Apr 2013

State roundup: S.F. looks into allegations of patient dumping

San Francisco will investigate allegations that Nevada has bused hundreds of indigent people with mental illnesses out of state, including to the Northern California city.

24 Apr 2013

BD receives FDA approval for second prefilled injectable drug

BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD, announced today that the U.S. Food and Drug Administration has approved the second drug to be offered in the recently launched BD Simplist line of ready-to-administer prefilled generic injectables.

From BD (Becton, Dickinson and Company) 24 Apr 2013

Janssen announces safety results from two Phase 3 studies of simeprevir in hepatitis C patients

Janssen R&D Ireland today announced primary efficacy and safety results from two global Phase 3 studies demonstrating that use of the investigational protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in 80 and 81 percent, respectively, of treatment-naive genotype 1 chronic hepatitis C adult patients with compensated liver disease, including all stages of liver fibrosis, when administered once daily with pegylated interferon and ribavirin.

24 Apr 2013

Isis Pharmaceuticals starts ISIS-SMNRx Phase 2 study in infants with SMA

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.

24 Apr 2013

Study finds health care spending will rebound when economy picks up

The analysis by The Kaiser Family Foundation says the slowdown in health spending over the past several years was largely driven by the economic malaise.

24 Apr 2013

U.S. on the verge of potentially devastating epidemic of untreatable gonorrhea

Gonorrhea has long been one of the most commonly-reported sexually transmitted diseases (STDs) in the U.S. and, unfortunately, with rising antimicrobial resistance, it has also become one of the most frightening for public health.

24 Apr 2013

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.

24 Apr 2013

Johns Hopkins study finds that medical interns spend just 12% of time with patients

Medical interns spend just 12 percent of their time examining and talking with patients, and more than 40 percent of their time behind a computer, according to a new Johns Hopkins study that closely followed first-year residents at Baltimore's two large academic medical centers.

24 Apr 2013

AACN awards Impact Research Grant to Detroit palliative care expert

The American Association of Critical-Care Nurses recently awarded an AACN Impact Research Grant to Margaret "Meg" Campbell, RN, PhD, FAAN, a nationally known expert in hospital-based palliative care and end-of-life issues.

24 Apr 2013

Some Boston Marathon bomb victims will face insurance coverage limits

ayments for prosthetics, rehabilitation and a range of other treatments may fall outside some insurance limits and could continue long into the future.

24 Apr 2013

Common species of bacteria contribute to bacterial vaginosis

New research at Washington University School of Medicine in St. Louis points to a common species of bacteria as an important contributor to bacterial vaginosis, a condition linked to preterm birth and increased risk of sexually transmitted diseases.

24 Apr 2013

Researchers examine impact of Allies Against Asthma initiative on health care use

Children living in areas where there was wide-ranging and active support for improving outcomes for their chronic asthma were hospitalized less and made fewer visits to the emergency room, when compared with those in other communities.

24 Apr 2013

UAB research shows ACE unit lowers costs, readmission rates for geriatric patient

It costs less to care for a geriatric patient hospitalized in a specialized Acute Care for Elders unit than it does for patients hospitalized in a more usual care setting, according to new research from the University of Alabama at Birmingham.

24 Apr 2013

Proposal would require insurers to report health law taxes

The measure's sponsor, Sen. John Cornyn, R-Texas, bills it as a way to educate consumers about how the health law's benefits are funded.

24 Apr 2013

Maternal use of valproate during pregnancy increases risk of autism in offspring

Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study in the April 24 issue of JAMA.

24 Apr 2013

Researchers uncover potential new way to fight obesity-related illness

A potential new way to fight obesity-related illness has been uncovered, thanks to serendipitous research led by investigators at the Case Western Reserve University School of Medicine.

24 Apr 2013

Doing moderate-intensity physical activity more critical to childhood cardiometabolic health

Researchers have discovered that participation in physical activity of at least moderate intensity is more critical to childhood cardiometabolic health than overall sedentary time.

24 Apr 2013

Medical News

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

Data from MK-5172 Phase II study for treatment of HCV genotype 1 infection to be presented at EASL meeting

Sucampo's supplemental new drug application for AMITIZA gets FDA approval

State roundup: S.F. looks into allegations of patient dumping

BD receives FDA approval for second prefilled injectable drug

Janssen announces safety results from two Phase 3 studies of simeprevir in hepatitis C patients

Isis Pharmaceuticals starts ISIS-SMNRx Phase 2 study in infants with SMA

Study finds health care spending will rebound when economy picks up

U.S. on the verge of potentially devastating epidemic of untreatable gonorrhea

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

Johns Hopkins study finds that medical interns spend just 12% of time with patients

AACN awards Impact Research Grant to Detroit palliative care expert

Some Boston Marathon bomb victims will face insurance coverage limits

Common species of bacteria contribute to bacterial vaginosis

Researchers examine impact of Allies Against Asthma initiative on health care use

UAB research shows ACE unit lowers costs, readmission rates for geriatric patient

Proposal would require insurers to report health law taxes

Maternal use of valproate during pregnancy increases risk of autism in offspring

Researchers uncover potential new way to fight obesity-related illness

Doing moderate-intensity physical activity more critical to childhood cardiometabolic health

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News